NCT06398821View on ClinicalTrials.gov

G3P-01 in Volunteers With Elevated Galectin-3

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 18, 2023

Primary Completion Date

April 16, 2024

Study Completion Date

May 30, 2024

Conditions
Galectin 3Healthy Aging
Interventions
DIETARY_SUPPLEMENT

G3P-01

Nutritional supplement to promote healthy aging

DIETARY_SUPPLEMENT

Placebo

Placebo

Trial Locations (1)

Unknown

General Practitioners Research Institute, Groningen

Sponsors

Collaborators (1)

G3 Pharmaceuticals
All Listed Sponsors
collaborator

G3 Pharmaceuticals

UNKNOWN

lead

General Practitioners Research Institute

NETWORK